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ABSTRACT
Hemophagocytic lymphohistiocytosis (HLH) is a rare and potentially fatal syndrome resulting from a hyperactivated immune 
system. Diverse patient profiles and clinical presentations often result in misdiagnosis. This article describes the varied 
clinical presentations and autopsy findings in three patients with this entity. The etiopathogenesis of HLH, its disparate 
and confounding clinical features, the diagnostic criteria, and management principles are also briefly reviewed. 
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INTRODUCTION
The immune system normally functions to 
protect the body from external and internal threats 
like pathogens and malignancies. At times, however, 
the immune system can ‘run amok’, and itself be a 
threat. Hemophagocytic lymphohistiocytosis (HLH) 
is a potentially life-threatening entity caused by 
an inappropriate over-activation of the immune 
system leading to a cytokine storm. Diverse clinical 
presentations that often overlap with other entities 
and the lack of sacrosanct diagnostic criteria often 
result in delayed diagnosis and significant morbidity 
and mortality.
This article presents the clinical, laboratory, and 
autopsy findings in three patients with HLH to elucidate 
the varied and confounding presentations in such 
patients. The etiopathogenesis, diagnostic criteria, 
and management principles are also briefly discussed.
CASE 1
A 50-year-old male patient diagnosed with 
disseminated Tuberculosis, on anti-tubercular therapy, 
presented with intermittent fever of one-month 
duration. He also had hepatosplenomegaly. Complete 
blood counts revealed anemia [hemoglobin (Hb)-8 g/dL 
(RR for adult males:13-17g/dL) and leukocytosis [total 
leukocyte count (TLC)-59,000/mm3 (RR: 4,000/mm3-
11,000/mm3)] with an abnormal differential leukocyte 
count (blasts-3%, polymorphs-56%, monocytes-14%, 
m y e l o c y t e s - 1 8 % ,  m e t a m y e l o c y t e s - 0 6 % , 
lymphocytes-03%). The platelet count was 2 x 105/mm3 
(RR:1.5 - 4.5 x105/mm3). Bone marrow aspiration, 
along with flow-cytometry, confirmed the diagnosis 
of Chronic Myelomonocytic Leukemia (CMML), and 
the patient was started on hydroxyurea therapy. 
After three months, he developed marked pallor with 
epistaxis and gingival bleeding. Bone marrow and 
peripheral smear examination revealed 59% blasts 
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(positive for myeloperoxidase). A diagnosis of Acute 
Myeloid Leukemia (AML) arising in a background of 
CMML was made, and he was started on induction 
chemotherapy. However, he developed severe 
chemotherapy-induced pancytopenia (Hb-6.5 g/dL, 
TLC-200/mm3, platelet count-2000/mm3). Granulocyte-
monocyte colony-stimulating factor was started, 
but the patient developed neutropenic sepsis with 
coagulopathy and acute renal failure and succumbed 
to his illness.
CASE 2
A 45-year-old male presented with a high 
fever, sore throat, cervical lymphadenopathy, and a 
non-pruritic maculopapular truncal rash of around 
three weeks duration. He also had polyarthralgia 
involving small and large joints. History of some 
unquantified weight loss was also elicited. Axillary and 
inguinal lymphadenopathy was present. Laboratory 
investigations revealed normocytic normochromic 
anemia (Hb-11.2 g/dL), leukocytosis (TLC-26,000/
mm3) with a neutrophilic predominance, and a normal 
platelet count. His erythrocyte sedimentation rate 
(ESR) and C-reactive protein were significantly raised 
at 120 mm/hr (RR: 0-15mm/hr) and 39 mg/dL (RR: 
<0.3 mg/dL), respectively. Serology for rheumatoid 
factor (RA factor), anti-nuclear antibodies (ANA), 
anti-double-stranded DNA (anti dsDNA) antibodies, 
anti-neutrophilic cytoplasmic antibodies (ANCA), HLA 
B-27, and anti-cyclic citrullinated peptide (anti-CCP) 
antibodies were all negative. He tested negative for 
Human Immunodeficiency Virus (HIV), Hepatitis B, and 
Hepatitis C. Venereal Diseases Research Laboratory 
(VDRL) test was non-reactive. The Mantoux test was 
negative. Computerized Tomography (CT) of the chest 
and abdomen revealed mediastinal and retroperitoneal 
lymphadenopathy with hepatosplenomegaly. Bilateral 
small pleural effusions and moderate ascites were 
present (Figure 1).
Cervical lymph node biopsy showed reactive 
paracortical hyperplasia; no necrosis, granulomata, 
or atypical cells were seen. Tissue sent for polymerase 
chain reaction (PCR) assay for Mycobacterium 
tuberculosis (MTB-PCR) was reported as negative. A 
diagnosis of adult-onset Still’s disease was considered 
as per Yamaguchi criteria.1 On the fourth day of 
admission, he developed Acute Respiratory Distress 
Syndrome (ARDS) with hypotension, severe metabolic 
acidosis, and acute liver and kidney injury. Laboratory 
investigations revealed bicytopenia with raised serum 
lactate dehydrogenase (LDH), triglycerides, ferritin, 
liver transaminases, and low fibrinogen levels. 
Peripheral blood smear showed a shift to the left and 
neutrophilic toxic granulations. ESR showed a drop 
to 20 mm/hr. In the background of adult-onset Still’s 
disease, Macrophage Activation Syndrome (MAS) was 
suspected. Despite aggressive measures, he succumbed 
to his illness after three days.
CASE 3
A 38-year-old male presented with high-grade 
fever and sore throat of three days duration. He was 
initially treated on an out-patient basis with oral 
antibiotics and antipyretics. After five days, he was 
brought to the hospital in a state of altered sensorium 
and severe breathlessness. An urgent CT chest 
was performed that showed bilateral parenchymal 
infiltrates associated with pleural effusions (Figure 2). 
He had two episodes of generalized tonic-clonic 
seizures followed by cardiac arrest soon after arrival 
Figure 1. A panel of contrast-enhanced axial CT scan images in soft-tissue window showing: A – Thoracic CT - bilateral 
pleural effusions (asterisk), bilateral axillary lymphadenopathy (arrows) and mediastinal lymphadenopathy 
(arrowheads); B – Abdominal CT - ascites (arrow) and retroperitoneal lymphadenopathy (arrowheads); C – Pelvic 
CT - bilateral inguinal lymphadenopathy (arrows).
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at the hospital, following which he was put on 
mechanical ventilation.
Peripheral blood smear showed pancytopenia 
with features of hemolysis, relative lymphocytosis, and 
activated lymphocytes. His liver and renal function tests 
and coagulation profile were deranged. An urgent 
CT scan of the head revealed hemorrhage in the left 
gangliocapsular region (Figure 3).
He suffered a second cardiac arrest within 
24 hours of hospital admission and could not be 
revived. The cause of death was attributed to MODS 
(multi-organ dysfunction syndrome), secondary to an 
infective febrile illness of possible viral etiology. The 
salient laboratory findings of the three patients are 
summarized in Table 1.
AUTOPSY FINDINGS
Autopsies were performed to ascertain the cause 
of death in all three patients. All viscera were preserved 
for histopathological examination.
Figure 2. A panel of axial non-contrast thoracic CT scan images showing: A – bilateral small pleural effusions 
(arrows), in the mediastinal window, and B – bilateral parenchymal infiltrates in lung window.
Figure 3. Axial non-contrast CT scan images of the brain showing a hematoma in the left gangliocapsular region 
(arrows).
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Salient gross findings
Case 1
The deceased was cachectic with the presence of 
pallor and bilateral pedal edema. Multiple petechial 
spots were seen over the thorax and abdomen. 
The lungs were heavy and congested (combined 
weight-1250g; RR:685g-1050g) (Figure 4A). Bilateral 
serosanguineous pleural effusions were noted (200 ml). 
The spleen was enlarged and congested (weight-175g; 
mRR-155g). The liver was enlarged (weight-1890g; RR: 
1500 g-1800g), and the anterior margin was rounded; 
the cut surface was unremarkable (Figure 4B). 
Multiple paratracheal, paraaortic, and peripancreatic 
lymph nodes were seen. 500ml of serosanguineous 
ascitic fluid was noted. Other organs were grossly 
unremarkable. Postmortem cultures of heart blood, 
pleural, peritoneal, and cerebrospinal fluid grew 
Klebsiella spp.
Case 2
The subject was averagely built and nourished. 
A maculopapular truncal rash with multiple petechial 
spots over the lower limbs was noted. Both lungs were 
subcrepitant and edematous with red, hyperemic 
cut surfaces (combined weight-1245g). Bilateral 
serosanguineous pleural effusions (500 ml) were 
noted. Multiple enlarged hilar and mediastinal 
lymph nodes were seen. The heart weighed 430g 
(RR: 270-360g). The right and left ventricular walls 
were thick and measured 1.5 cm and 2 cm in thickness, 
respectively (mRR: right ventricle-0.5cm, left ventricle-
1.5cm) (Figure 5A). No mural thrombus/ infarct 
was seen. The liver was enlarged (weight-1750 g); 
the cut surface was unremarkable. The spleen was 
enlarged (weight – 260g; mRR-155g) and congested 
(Figures 5B, 5C). Abdominal lymphadenopathy was 
noted. Cultures of heart blood and pleural fluid 
showed no growth.
Case 3
The subject was averagely built and nourished. 
The lungs were congested (combined weight-1420g). 
Bilateral sero-sanguineous pleural effusions (500 ml) 
were present.
Multiple paratracheal and peribronchial lymph 
nodes were noted. The liver was enlarged, tense, and 
cyanotic (weight-1960g); the cut surface appeared 
Table 1. Ante-mortem laboratory parameters of patients 
Case 1 Case 2 Case 3 Normal range
Diagnosis CMML in blast crisis Adult-onset Still’s disease Septic shock, acute respiratory illness (? Viral)
Hb (g/dl) 6.5 10.2 6.8 12-17 g/dl
TLC (/mm3) 200 26,000 1,900 4000-11,000
DLC PMN 20%, Ly 80% PMN-90%(Bands-30%), Ly-10%
PMN-32%, Ly-60%, 
Mo-08%
Platelets (/mm3) 2,000 8,0000 10,000 1.5-4.5 x 105
INR 3.25 3.75 5.25
ESR (mm/hr) 46 120 68 <20
CRP (mg/L) 160 89 78 <0.3
bilirubin (mg/dL) 2.3 1.8 3.4 0.2-1.2
AST (IU/L) 389 470 850 5-40
ALT (IU/L) 288 397 679 7-56
Ferritin (mcg/L) 6900 18500 11980 20-250
Triglycerides (mg/dL) 270 494 342 <150
LDH (IU/L) 895 4482 3376 140-280
Fibrinogen (g/L) - 1.8 1.0 2-4
ALT= alanine aminotransferase, AST= aspartate aminotransferase, CMML=chronic myelomonocytic Leukemia, DLC= 
differential leukocyte count, ESR= Equipment sedimentation ratio, Hb= hemoglobin, INR= International normalized ratio, 
LDH= lactate dehydrogenase, Ly= lymphocyte, M= monocyte, PMN= polymorphonuclear, TLC= total leukocyte count. In 
case 3 - presence of schistocytes, polychromasia and nucleated RBC in the peripheral blood smear.
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variegated and mottled red (Figure 6A). The spleen 
was enlarged, congested, and friable (weight-180 g). 
The brain weighed 1450g (RR:1100-1700g). On the 
cut section, a hematoma measuring 3.5 cm x2.5cm 
was seen in the left basal ganglia extending into the 
left ventricle (Figure 6B). No evidence of cerebral 
herniation was noted. Post-mortem tracheal and 
nasopharyngeal aspirates were tested for Influenza 
A & B, pandemic A (H1N1), Respiratory syncytial 
viruses (RSV A & B), Human Metapneumovirus 
(hMPV), Parainfluenza viruses (PIV 1-4), Rhinovirus, 
Adenovirus. The aspirate was positive for (H1N1). 
Cultures of heart blood and pleural fluid showed no 
growth.
Salient histopathological findings
In all three cases, sections from the lungs showed 
features of diffuse alveolar damage. There was 
congestion along with an interstitial and intra-alveolar 
accumulation of fluid, fibrin, and the presence of mixed 
inflammatory infiltrate. The alveolar walls were lined 
with waxy, hyaline membranes. A variable number of 
hemosiderin-laden alveolar macrophages (heart failure 
cells) was noted (Figure 7).
Sections from the liver in cases 1 and 2 showed 
chronic hepatitis-like features (steatosis, spotty 
necrosis, sinusoidal congestion, and dilatation with 
periportal lymphomononuclear inflammatory cell 
Figure 4. Gross view of organ specimens from case 1 showing: A – heavy, congested lungs, and B – an enlarged 
liver with rounded anterior margins.
Figure 5. Photographs of organ specimens from case 2: A – cut section of heart showing thick ventricular walls, 
B – gross view of the enlarged congested spleen, and C – cut section of the spleen.
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infiltrate). In case 3, there was centrilobular congestion, 
hemorrhage, and necrosis (Figure 8).
Sections from the kidneys in all cases showed 
features of acute tubular necrosis with desquamation 
of epithelial cells into the tubular lumen (Figure 9).
Diagnostic histopathological findings of HLH were 
noted in the lymph nodes, bone marrow, and spleen 
in all three cases. Massive sinusoidal dilatation and 
infiltration by histiocytes engorged with phagocytosed 
erythrocytes, granulocytes, and lymphocytes were 
seen in lymph node sections (Figure 10A). Smears 
from bone-marrow showed depleted hematopoietic 
precursors along with the proliferation of macrophages 
exhibiting hemophagocytosis (Figure 10B). Splenic 
sections revealed attenuated white pulp with 
extensive infiltration by hemophagocytic histiocytes 
(Figure 10C).
Lymphocytic myocarditis was noted in the 
posterior wall of the left ventricle in case 2 (Figure 11). 
Immunohistochemistry (IHC) panel comprising CD3, 
CD68, CD45RO was employed to demonstrate 
myocarditis (as per Dallas criteria guidelines). This 
finding can be attributed to the patient’s underlying 
autoimmune disease.
In case 3, sections from the brain showed left 
gangliocapsular hematoma (and liquefactive necrosis) 
(Figure 12). Cerebral edema was suggested by the 
prominence of Virchow Robin’s spaces, swelling of 
neurons with a widening of perivascular spaces, and 
Figure 6. A – Detail of a cut sections of the liver with a variegated and mottled appearance of the liver (nutmeg 
liver), B – a hematoma in left basal ganglia (scale bar = 7 cm).
Figure 7. A photomicrograph of lung showing interstitial 
and intra-alveolar accumulation of mixed inflammatory 
infiltrate and waxy, hyaline membrane (H&E, 40X).
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congestion of blood vessels. No granuloma/ organism 
was seen. In cases 1 and 2, sections from the brain 
were largely unremarkable except for some mild 
cerebral edema in case 2.
The autopsy findings are tabulated in Table 2.
DISCUSSION
HLH is a rare, life-threatening disorder characterized 
by an inappropriate hyper-activation of the immune 
system. Farquhar and Claireux first described it in 1952 
in siblings.2 ‘Primary’ or ‘Familial’ HLH is a rare entity 
occurring in infants and young children that results 
from mutations in genes regulating the function of the 
cytotoxic T-lymphocytes (CTLs) and the natural killer 
(NK) cells.3 In contrast, secondary or acquired HLH may 
be triggered by infections, malignancy, or autoimmune 
diseases.2-5 The annual incidence is reported to be 
approximately 1.2 cases per million, though it is 
likely that many cases go undiagnosed.6 Macrophage 
Activation Syndrome (MAS) is a subset of HLH which 
occurs in the setting of autoimmune diseases like 
systemic-onset juvenile idiopathic arthritis (sJIA), and 
its adult equivalent adult-onset Still’s disease, systemic 
lupus erythematosus, Kawasaki disease, and some 
periodic fever syndromes.7
Based on data accrued from HLH-94 (the first 
prospective international treatment protocol sponsored 
by the Histiocyte Society) as well as other studies, the 
Histiocyte Society treatment protocol HLH-2004 was 
formulated which laid down the diagnostic guidelines 
for HLH (Table 3).9
However, it includes criteria like the assessment of 
Natural Killer (NK) cell activity and soluble CD 25 levels, 
facilities for which are not widely available. Hence, the 
H score formulated by Fardet et al.10 may be a more 
practical diagnostic alternative (Table 3).
In our series, all three patients presented with high 
fever, hepatosplenomegaly, lymphadenopathy, and 
MODS features (acute respiratory distress syndrome, 
acute kidney, and liver injury with coagulopathy). 
Pancytopenia was documented in two patients, while 
one patient presented with neutrophilic leukocytosis 
and a normal platelet count. Serum ferritin, triglycerides, 
and LDH were significantly elevated in all. In all cases, 
hemophagocytosis was demonstrated in the bone 
Figure 8. Photomicrographs of the liver showing: A – steatosis (black arrowhead) with periportal inflammatory 
infiltrate (white arrowhead) in case 1 (H&E 10X); B – dilated hepatic sinusoids (white arrowhead) with spotty necrosis 
(black arrowhead) in case 2 (H&E, 40X magnification); and C – centrilobular congestion and hemorrhage in case 3 
(H&E, 10X magnification).
Figure 9. A photomicrograph of kidneys showing 
extensive tubular necrosis (H&E, 40X).
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Figure 10. Photomicrographs showing hemophagocytosis by macrophages in A – lymph node (H&E, 10X 
magnification), B – bone-marrow (H&E, 10X magnification), and C – spleen (H&E, 40X magnification).
Figure 11. A photomicrograph showing lymphocytic 
infiltrates in the myocardium (H&E, 40X magnification).
Figure 12. A photomicrograph showing liquefactive 
necrosis of brain parenchyma with hemorrhage (H&E, 
10X magnification).
Table 2. Autopsy findings in all three patients with HLH
Case 1 Case 2 Case 3
Gross findings






Heavy, boggy lungs; Sero-
sanguineous pleural effusion; 
cardiomegaly; multiple 
thoracic, abdominal lymph 
nodes; hepatosplenomegaly.
Heavy, boggy lungs; sero-
sanguineous pleural effusion; 
nutmeg liver; multiple 
enlarged paratracheal; 
peribronchial lymph nodes; 
congestive splenomegaly; left 
gangliocapsular hematoma.
Heart blood/CSF/ Ascitic/ 
Pleural culture Klebsiella pneumonia No growth No growth
Post-mortem tracheal & 
nasopharyngeal aspirate - - Pandemic A (H1N1)
Microscopy
Hemophagocytosis in bone-
marrow, spleen & lymph 
nodes; diffuse alveolar 
damage lungs; steatosis with 
spotty necrosis & periportal 
inflammation in liver, acute 
tubular necrosis in kidneys
Hemophagocytosis in 
bone marrow, spleen & 
lymph nodes; lymphocytic 
myocarditis; diffuse alveolar 
damage lungs; steatosis with 
periportal inflammation & 
spotty liver necrosis; acute 
tubular necrosis in kidneys
Hemophagocytosis in bone 
marrow, spleen & lymph 
nodes; diffuse alveolar 
damage lungs; acute 
passive congestion in liver, 
acute tubular necrosis in 
kidneys; left gangliocapsular 
hematoma with liquefactive 
necrosis of brain parenchyma
‘CSF’ stands for ‘Cerebrospinal fluid’.
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Table 3. Diagnostic Criteria for HLH/MAS
Based on HLH 2004 2016 classification criteria for MAS complicating sJIA (Ravelli et al.8)
1. Molecular diagnosis (Confirmed HLH associated genetic 
mutation)
A known or suspected patient of sJIA with fever is classified as 
having MAS if the following criteria are met:
Or · Ferritin >684ng/ml and
2. Fulfilment of 5 out of the following 8 criteria: · Two of the following:
(a) Fever o Platelet count ≤ 181x109/l
(b) Splenomegaly o AST> 48U/l
(c) Cytopenias in peripheral blood (affecting at least 2 
hematopoietic cell lineages): o Triglycerides >156 mg/dl
- Hemoglobin < 90 gm/L o Fibrinogen≤360mg/dl
(<100gm/L in infants < 4 weeks of age)
-Platelets < 10x109 /L
-Neutrophils <10x109/L
(d) Hypertriglyceridemia and/or hypofibrinogenemia:
-Fasting triglycerides ≥3.0 mmol/L (ie, ≥265 mg/dL)
-Fibrinogen ≤1.5 g/L
e) Hemophagocytosis in the bone marrow, spleen, or lymph 
nodes
f) Low or absent natural killer cell activity
g) Ferritin ≥500 ng/mL
h) Soluble CD25 (ie, soluble interleukin-2 receptor) ≥2,400 U/mL
Based on the ‘H’ Score





immunosuppression 0 (no) or 18 (yes) 90 <1
Temperature (0C)
0(<38.4), 100 1








0(1 lineage) 150 25
24(2 lineages) 160 40

















on bone marrow aspirate
0 (No)
35(Yes)
Hb ≤ 9.2gm/dl; Leukocyte count ≤5000/mm3; Platelet count ≤1,10,000/mm3
HIV positive/On long term immunosuppressive therapy (Glucocorticoids/Cyclosporine/Azathioprine)
Best cut-off for H score - 169
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marrow, spleen, and lymph nodes at post-mortem. 
The calculated H-score with probability for HLH in our 
patients is depicted in Table 4.
While two patients had severe leukopenia, one 
had leukocytosis. This finding has been documented 
in cases of MAS.7,11,12 MAS is considered a diagnostic 
challenge as symptoms are non-specific, appear late, 
and are difficult to distinguish from a concurrent 
flare-up of the underlying autoimmune condition 
or coexisting systemic infection. Moreover, patients 
with autoimmune diseases often have preexisting 
leukocytosis, thrombocytosis, hyperferritinemia, and 
hyperfibrinogenemia as a part of the underlying 
inflammatory condition. In such patients, even with 
the onset of MAS, the TLC/platelet count/ fibrinogen 
level may be paradoxically normal. Hence, the cut-off 
values for cytopenias, ferritin, and fibrinogen levels, as 
defined in HLH-2004, may not be applicable. Based on 
expert opinion, available medical literature, and real 
patient data, Ravelli et al.8 proposed diagnostic criteria 
for MAS in patients of sJIA. These diagnostic criteria 
include 5 laboratory variables, along with one clinical 
criterion (fever) (Table 3). In case 2 of our series, 4 
out of these 5 variables (ferritin, platelet count, AST, 
triglycerides) showed a >50% rise from pre-MAS 
values, out of which serum ferritin showed the most 
significant rise. Minoia et al.13 and Kostik et al.14 also 
tried to define the best cut-off points for laboratory 
parameters and the most relevant clinical symptoms 
for diagnosing MAS. However, all these studies were 
conducted in pediatric patients of sJIA, and their 
applicability in adult patients is debatable. The clinical 
picture and laboratory parameters may get further 
vitiated in the setting of active treatment with IL-1 or 
IL-6 blockade.7
In case 2, there was a notable change in the 
pattern of fever post-MAS. From intermittent high 
grade in nature, the fever pattern became continuous 
non-remitting with the onset of MAS. The laboratory 
parameters also consistently pointed to a MAS 
diagnosis, while the serum ferritin rose to 18,500mcg/L 
(from 5780 mcg/L), his TLC, platelet count, and 
fibrinogen also showed a >50% rise from baseline 
levels. This suggests that daily laboratory parameters 
monitoring to detect subtle alterations may be crucial 
in the early diagnosis of MAS. A rise in ferritin coupled 
with a concomitant fall in ESR (due to consumption 
of fibrinogen and decreased hepatic synthesis) may 
serve as an early marker of MAS. Ferritin to ESR ratio 
of ≥ 21.5 was found to have 82% sensitivity and 78% 
specificity in distinguishing MAS from an autoimmune 
flare.15
At autopsy, the lungs showed features of diffuse 
alveolar damage with serosanguineous pleural effusion 
in all cases; this finding was likely to be a part of the 
spectrum of MODS. Limited literature is available 
on lung involvement in HLH/MAS. Seguin et al.16 
found lung involvement in 118 (54%) out of 219 
patients with HLH. Dyspnea and cough were the 
most common symptoms. On imaging, alveolar and 
interstitial infiltrate, centrilobular nodules, ground-
glass opacities, consolidation, pleural effusion, and 
mediastinal lymphadenopathy were noted. Underlying 
causes of lung involvement included infections in 
52 patients, pulmonary edema associated with heart 
failure in 34 patients, and malignancies (lymphoma) in 
22 patients. Lung involvement in HLH carried a poor 
prognosis with a mortality rate of 52.5% versus 20% 
in patients without pulmonary involvement.16 A few 
studies have also documented pulmonary hemorrhage, 
bronchiolitis, and lymphangitic spread of mononuclear 
cells.17,18 Hemophagocytosis has been reported in the 
lungs in pediatric patients.19
Liver findings in HLH have been well studied.20,21 
Hyperbilirubinemia with elevated transaminases 
[ A s p a r t a t e  t r a n s a m i n a s e  ( A S T ) > A l a n i n e 
aminotransferase (ALT)] reflects the degree of liver 
dysfunction. Four distinct histological patterns have 
been described: (a) chronic hepatitis-like, (b) leukemia-
like, (c) histiocyte storage disorder-like, and (4) 
neonatal giant cell hepatitis-like.21 The most common 
pattern is a chronic hepatitis-like picture characterized 
by Kupffer cell hyperplasia, portal, and sinusoidal 
infiltrate of cytotoxic T-cells with a variable number 
of hemophagocytic histiocytes. Varying degrees of the 
portal and central vein endothelialitis, lymphocytic bile 
duct injury, sinusoidal congestion, and dilatation along 
with non-specific features like hepatocellular necrosis, 




Case 1 287 >99
Case 2 327 >99
Case 3 299 >99
Majumder A, Sen D
11-13Autops Case Rep (São Paulo). 2021;11:e2021243
steatosis, cholestasis, and hemosiderosis are seen.21 
In our autopsy series, liver histology demonstrated 
a chronic hepatitis-like picture in two cases, while 
one case had non-specific centrilobular hemorrhagic 
necrosis, probably secondary to circulatory failure. 
However, no hemophagocytosis could be demonstrated 
(Table 2). Lymphocytic myocarditis was demonstrated 
in one case (Case 2).
Hemophagocytosis, which is the histopathological 
sine qua non finding for the diagnosis of HLH, has 
been demonstrated in the bone marrow, spleen, lymph 
nodes, lungs, liver, skin, meninges, CSF, and rarely in 
subcutaneous tissue.4-6,22-24 However, hemophagocytosis 
is often cyclical, which may necessitate multiple bone 
marrow biopsies.22-24 Moreover, hemophagocytosis is 
not specific to HLH; it has also been noted in 60% of 
patients with severe sepsis who do not fulfill the criteria 
for HLH.24 This has been attributed to the suppression 
of NK cell activity in severe sepsis. These findings point 
to a need to review the HLH–2004 guidelines, which 
include hemophagocytosis as one of the defining criteria 
for HLH.
A notable finding in HLH is the central nervous 
system (CNS) involvement. More commonly seen in 
pediatric patients with familial HLH, cerebral HLH is rare 
in adults and, when present, is usually associated with a 
high degree of mortality and neurological sequelae. In 
a study by Cai et al.25, of 289 adult patients with HLH, 
only 10% had CNS involvement. The symptoms range 
from seizures, altered mental state, meningitis, ataxia, 
hemiplegia, encephalopathy, cranial nerve palsies 
to simple irritability. Magnetic Resonance Imaging 
(MRI) may reveal nodular parenchymal lesions along 
with leptomeningeal enhancement, demyelination, 
atrophy, and acute necrotizing encephalopathy (ANE). 
Isolated cases of subdural hemorrhage have also 
been reported.26,27 An uncommon but fatal finding 
is the intracerebral hemorrhage, which may be a 
consequence of DIC that commonly accompanies HLH. 
Cerebrospinal fluid (CSF) analysis in suspected cases 
of cerebral HLH may reveal pleocytosis, increased 
proteins, and occasionally hemophagocytosis.28 
However, most cases have non-specific neuroimaging 
and CSF findings. In our study, one patient presented 
with an altered mental state and was detected to have 
intracerebral hemorrhage on CT scan. This suggests 
the need for early imaging in HLH patients with CNS 
symptoms.
Mutation analysis studies should ideally be 
performed in all suspected HLH patients as characteristic 
gene mutations preclude the need to fulfill other 
diagnostic criteria. Tests include measurements of 
NK-cell activity by the 51-Cr release assay and soluble 
CD25 (sCD25) levels by immunoassay. Emerging 
biomarkers like soluble CD163, IL-18, and FSTL-1 
(follistatin-related protein 1) may be considered in the 
diagnosis of MAS.29,30 However, their availability and 
application remain a challenge.
The HLH 94 treatment protocol consists of 
corticosteroids, cyclosporine A, intrathecal therapy 
with Methotrexate, and etoposide. However, 
the heterogeneity of HLH calls for individualized 
treatment protocols, particularly in elderly patients 
with comorbidities who are more prone to end-organ 
damage. In acquired HLH, identification and concurrent 
treatment of the underlying cause is important. Cases 
of refractory HLH may benefit from a combination 
of intensified chemotherapy and allogeneic stem cell 
transplant. Some of the salvage agents approved in 
refractory cases include alemtuzumab (anti-CD 52 
antibody) and emapalumab (anti-IFNy monoclonal 
antibody). A notable addition to the arsenal is 
tocilizumab (anti-IL-6 antibody), which has been used 
to treat cancer patients with immunotherapy induced 
cytokine storms.31
CONCLUSION
This article highlights the varied clinical and 
biochemical profile and autopsy findings in three 
patients with HLH. Cytopenias that are widely 
regarded as definite diagnostic criteria for HLH may 
present late or even be absent. Hemophagocytosis 
may be cyclical and is not specific to HLH. Also, a 
diagnosis of HLH may be confounded by preexisting 
hepatosplenomegaly in patients with underlying 
hematolymphoid malignancies, infections, and auto-
immune disorders. Thus, deranged liver and renal 
function, coagulopathy along with elevated ferritin 
and triglycerides may be early harbingers of this 
condition. Though our understanding of the complex 
pathophysiology of HLH has increased, much work 
remains to be done for unambiguous early diagnosis 
and management of this oft-missed and potentially 
fatal entity.
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